Strong

Our patients don’t just live with diabetes, they thrive with diabetes.

Leading

We’re constantly pushing forward toward the next great discovery.

Joslin and COVID-19

At Joslin Diabetes we are committed to providing the very best and safest care possible. In response to the COVID-19 pandemic, Joslin has shifted to a remote model of care for our patients. Our remote care model with limited, in-person “urgent care” appointments means: In-clinic appointments are limited to very urgent appointments which must be authorized by the Joslin provider. Patients should...
Joslin's Response to Covid-19

Better Pregnancy Spacing Would Aid Those With Gestational Diabetes

Women with a history of gestational diabetes were 50% more likely to have a short interval between pregnancies (18 months or less) compared with women without gestational diabetes, in a new study.
Read more on Better Pregnancy Spacing Would Aid Those With Gestational Diabetes

Continuous Glucose Monitoring Helps Young People with Type 1 Diabetes Achieve Better Glycemic Control

Study Highlights: Six-month clinical trial shows that continuous glucose monitoring (CGM) helps adolescents and young adults manage their type 1 diabetes more effectively, compared with daily use of...
Read more on Continuous Glucose Monitoring Helps Young People with Type 1 Diabetes Achieve Better Glycemic Control

Joslin and COVID-19

At Joslin Diabetes we are committed to providing the very best and safest care possible. In response to the COVID-19 pandemic, Joslin has shifted to a remote model of care for our patients. Our remote care model with limited, in-person “urgent care” appointments means: In-clinic appointments are limited to very urgent appointments which must be authorized by the Joslin provider. Patients should...
Joslin's Response to Covid-19

Promising treatment to slow kidney disease doesn’t prove out in clinical trial

Scientists find that reducing levels of uric acid in the blood does not guard against complication in type 1 diabetes. BOSTON – (June 25, 2020) – Historically, half or more of people with type 1...
Read more on Promising treatment to slow kidney disease doesn’t prove out in clinical trial

Continuous Glucose Monitoring Helps Young People with Type 1 Diabetes Achieve Better Glycemic Control

Study Highlights: Six-month clinical trial shows that continuous glucose monitoring (CGM) helps adolescents and young adults manage their type 1 diabetes more effectively, compared with daily use of...
Read more on Continuous Glucose Monitoring Helps Young People with Type 1 Diabetes Achieve Better Glycemic Control

Joslin and COVID-19

At Joslin Diabetes we are committed to providing the very best and safest care possible. In response to the COVID-19 pandemic, Joslin has shifted to a remote model of care for our patients. Our remote care model with limited, in-person “urgent care” appointments means: In-clinic appointments are limited to very urgent appointments which must be authorized by the Joslin provider. Patients should...
Joslin's Response to Covid-19

Promising treatment to slow kidney disease doesn’t prove out in clinical trial

Scientists find that reducing levels of uric acid in the blood does not guard against complication in type 1 diabetes. BOSTON – (June 25, 2020) – Historically, half or more of people with type 1...
Read more on Promising treatment to slow kidney disease doesn’t prove out in clinical trial